Articles in international peer reviewed journals 2009 – 2015

Owen E, Leisegang F, Whitelaw A, Simpson J, Würzner R, Morgan B, Potter PC, Orren A. A complement C5 gene mutation, c.754G>A:p.A252T, is common in the Western Cape, South Africa and found to be homozygous in seven percent of Black African meningococcal disease cases. Molecular Immunology, 2015; 64: 170-176.
Potter PC, Baker S, Fenemore B, Nurse B. Clinical and cytokine responses to house dust mite sublingual immunotherapy. Ann Allergy Asthma Immunol, 2015. (published online February 2015) doi:10.1016/j.anai.2014.12.015
Potter PC, Ehrlich R, Van Rooyen C, Fenemore B. Occupational sensitization to the African penguin serum and mucus proteins. Annals of Allergy, 2015. (published online February 2015)
Potter P, Mitha E, Mezei G, Santamaria E, Izquierdo I, Maurer M. Rupatadine is effective in the treatment of chronic spontaneous urticaria in children aged 2-11 years: a randomized, double blind, placebo and desloratadine controlled study. Pediatr Allergy Immunol 2015: 00. doi:10.1111/pai.12460
Gray C, Levin M, Zar H, Potter PC, Khumalo N, Volkwyn L, Fenemore B, Du Toit G. Food allergy in South African children with atopic dermatitis. Paediatric Allergy & Immunology, 2014; 25: 572-579.
Potter P, Maspero JF, Vermeulen J, Barkai L, Nemeth I, Baillieau RA, Garde JM, Girait J, Domenech A, Izquierdo I, Nieto A. Rupatadine oral solution in children with persistent allergic rhinitis: A randomized, double-blind, placebo-controlled study. Pediatr Allergy Immunol, 2013; 24: 144-150.
Potter P. Sublingual immunotherapy in Southern Africa: Lessons learned. J Allergy Clin Immunol, 2013; 132: 99-100.
Passalacqua G, Baena-Cagnani CE, Bousquet J, Canonica GW, Casale TB, Cox L, Durham SR, Larenas-Linnemann D, Ledford D, Pawankar R, Potter P, Rosario N, Wallace D, Lockey RF. Grading local side effects of sublingual immunotherapy for respiratory allergy: Speaking the same language. J Allergy Clin Immunol, 2013; 132: 93-8.
Potter PC, Pawankar R. Indications, efficacy and safety of intranasal corticosteroids in rhino sinusitis. World Allergy Organization Journal online, January 2012; 5: S14-S17.
Taborda-Barata L, Potter PC. Socio-epidemiological aspects of respiratory allergic diseases in Southern Africa. World Allergy Organization Journal, January 2012; 5(1):1-8.
Orren A, Owen EP, Henderson HE, Van der Merwe L, Leisegang F, Stassen C, Potter PC. Complete deficiency of the sixth complement component (C6Q0), susceptibility to Neisseria meningitides infections and analysis of the frequencies of C6Q0 gene defects in South Africans. Clinical and Experimental Immunology, March 2012; 167 (3): 459-471 (doi: 10.1111/j.1365-2249.2011.04525.x).
Katelaris CH, Lee BW, Potter PC, Maspero JF, Congi C, Lopatin A, Saffer M, Xu G, Walters RD. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy, February 2012; 42(2): 186-207 (doi: 10.1111/j.1365-2222.2011.03891.x).
Maspero J, Lee BW, Katelaris CH, Potter PC, Cingi C, Lopatin A, Saffer M, Nadeau G, Walters RD. Quality of life and control of allergic rhinitis in patients from regions beyond Western Europe and the USA. Clinical & Experimental Allergy, December 2012; 42(12): 1684-1696 (doi: 10.1111/j.1365-2222.2012.04025.x).
Coovadia KM, Potter PC. Guest Editorial - Medical Management of Adenoidal Hypertrophy: An Evidence Based Approach. MSAI Newsletter, January 2012; 13: 2-3.
Bousquet J, Schuneman HJ, Cagnani CB, Potter PC et al. ARIA (Allergic Rhinitis and Its Impact on Asthma): Achievements in 10 years and future needs. J Allergy Clin Immunol 2012; 130(5): 1049-1062.
Sanchez-Borges M, Asero R, Ansotegui I, Baiardini I, Bernstein J, Canonica GW, Gower R, Kahn DA, Kaplan AP, Katelaris C, Maurer M, Sim Park H, Potter PC, Saini S, Tassinari P, Tedeschi A, Min Ye Y, Zuberbier T. Diagnosis and treatment of Urticaria and Angioedema: A Worldwide Perspective. World Allergy Organization Position Paper. World Allergy Organization Journal 2012; 5: 125-147.
Katelaris CH, Lee BW, Potter PC, Maspero JF, Cingi C, Lopatin A, Saffer M, Xu G, Walters RD. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin and Exp Allergy, 2011; 1-22. DOI: 10.1111/j.1365-2222.2011.03891x
Lumry WR, Henry Li H, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom B, Reshof A. Randomized placebo controlled trial of Bradykinin B2 receptor antagonist Icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol, 2011; 107: 529-537.
Kung SJ, Fenemore B, Potter PC. Anaphylaxis to Mopane worms (Imbrasia Belina). Ann Allergy, 2011; 106: 538-540.
Potter PC. Current guidelines for the management of asthma in young children. Allergy Asthma and Immunology Research, 2010; 2(1): 1-13 (
Potter PC. Treatment of asthma in children under 5 years based on different global guidelines. WAO online, January 2010.
Warner JO, Rosario N, Wahn U, Potter PC, Baena-Cagnani C. A children’s asthma charter. Paediatric Allergy and Immunology, 2010; 21: 1-2.
Pedersen S, Potter PC, Dacher S, Bosheva M, Kazmarck J, Springer E, Dunkel J, Engelstatter R. Efficacy and safety of three doses of ciclesonide versus placebo in children with asthma: the Rainbow Study. Respiratory Medicine 2010, 104: 1618-1628.
Meurer M, Eichenfield LF, Ho V, Potter PC, Werfel T, Hultsch T. Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: a randomized, double-blind trial. J Dermatolog Treat. 2010 May; 21(3): 157-66.
Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schünemann HJ; Global Allergy and Asthma European Network; Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010 Sep; 126(3): 466-76.


Potter PC, Kapp A, Maurer M, Guillet G, Anca M, Hauptman P, Finlay Y. Comparison of the efficacy of levocetirizine 5mg and desloratadine 5mg in chronic idiopathic urticaria. Allergy 2009; 64: 596-604.
Potter PC. Clinical responses to sublingual immunotherapy in allergic diseases and asthma. Asthma 2009, Vol 10 (Suppl): 32-33.
Potter PC. Managing asthma in young children: An update on new Guidelines. Asthma 2009, Vol 10 (Suppl): 39-38.
Bousquet J, Bachert C, Canonica G et al. On behalf of the World Allergy Organization and Allergic Rhinitis and Its Impact on Asthma Study Groups. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol, 2009; 124: 428-433.
Dde Benedictis FM, Franceschini F, Hill D, Naspitz C, Simons FE, Wahn U, Warner JO, de Longueville M; EPAAC Study Group. The allergic sensitization in infants with atopic eczema from different countries. Allergy. 2009 Feb; 64(2): 295-303.
Potter PC, Pawankar R et al (Eds). Sublingual Immunotherapy in Allergic Rhinitis and Asthma. Allergy Frontiers, Therapy and Prevention. Springer, 2009; 5: 215-224.
Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawankar R, Potter PC. World Allergy Position Paper on Sublingual Immunotherapy 2009. (In press: World Allergy Organization Journal and Allergy).
Potter PC, Warner JO, Pawankar R, Kaliner M, Del Giacco S, Rosenwasser L. On behalf of the WAO Speciality and Training Council. Recommendations for Competency in Allergy Training for Undergraduates Qualifying as Medical Practitioners: A Position Paper of the World Allergy Organization. WAO Journal, August 2009; 2: 150-154.